Literature DB >> 3504285

Intracranial arteriovenous anomalies of infancy: modern concepts.

J C Godersky1, A H Menezes.   

Abstract

A variety of cerebrovascular abnormalities may become manifest in the first years of life. We present our recent experience with 7 children, ages 1 week to 7 months of age, who presented with congestive heart failure and progressive head enlargement (3), heart failure alone (1) and head enlargement alone (2). The anomalies include vein of Galen aneurysm (3), complex arteriovenous fistula (2) and posterior fossa dural arteriovenous malformations (2). Computed tomographic scanning was invaluable in delineating the site of the lesion while arterial digital subtraction angiography was utilized to obtain the high-quality images, reduced dye volume and rapid filming. Direct surgical intervention was accomplished in 5 cases, while embolization was utilized in 2. One child underwent direct partial occlusion and embolization. Congestive heart failure resolved in 2 of 3 operated cases and improved in those undergoing embolization. Hydrocephalus improved in 2 cases with the elimination of the fistula. Morbidity included seizures and a hemorrhagic infarction in 1 case. Neurologic outcome was satisfactory and there was no surgical mortality.

Entities:  

Mesh:

Year:  1987        PMID: 3504285     DOI: 10.1159/000120337

Source DB:  PubMed          Journal:  Pediatr Neurosci        ISSN: 0255-7975


  3 in total

1.  Colour Doppler imaging of arteriovenous malformation of the vein of Galen in a newborn.

Authors:  K H Deeg; J Scharf
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Endovascular treatment of an infantile nongalenic cerebral arteriovenous fistula with cyanoacrylate.

Authors:  M Hermier; F Turjman; A Bozio; J Duquesnel; C Lapras
Journal:  Childs Nerv Syst       Date:  1995-08       Impact factor: 1.475

3.  Congestive heart failure in neonates due to intracranial arteriovenous malformation: endovascular treatment.

Authors:  M E McConnell; P Aronin; J J Vitek
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.